ZBH | Zimmer Biomet HoldingsNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$97.06
-$0.29 (-0.30%)

Zimmer Biomet Holdings (ZBH) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat above the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits above the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $97.06 vs 50 $94.69 / 200 $91.72
Projection
No cross projected
Test
No active test
Last cross
Golden cross 13 Aug 2026 ยท projected 27 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $94.52 vs 50 $91.76 / 200 $108.40
Projection
No cross projected
Test
No active test
Last cross
Death cross week of 30 May 2022 ยท projected 26 bars out

4-hour as of 3 Nov 16:00 ET

Price
above both $97.06 vs 50 $93.43 / 200 $93.74
Projection
Golden cross projected in 3 bars
Test
No active test
Last cross
Death cross 12 Oct 2026 bar 2 ยท projected 28 bars out ยท tested 5 bars

Cross history

32
crosses on record since 2017
15 golden17 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
12 Oct 2026Death4-hour28 bars out5 bar cross test
13 Aug 2026Golden moderatedaily27 bars outNot tested
17 Jul 2026Golden4-hour25 bars out6 bar cross test
6 Apr 2026Death4-hour25 bars out5 bar cross test
3 Mar 2026Golden4-hour27 bars out3 bar cross test

About ZBH

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$175M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.